Vaxxinity, Inc.

Quick facts

Marketed products

• BNT162b2 vaccine · Infectious Disease
  Not specified

Phase 3 pipeline

• ChAdOx1-S vaccine · Immunology / Infectious Disease
  ChAdOx1-S is a viral vector vaccine that delivers the SARS-CoV-2 spike protein gene to stimulate adaptive immune responses against COVID-19.
• Sinopharm BIBP · Immunology / Infectious Disease
  Sinopharm BIBP is a COVID-19 inactivated vaccine that stimulates immune responses against SARS-CoV-2 by presenting inactivated viral particles to the immune system.

Phase 1 pipeline

• UB-313
• VXX-401

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Vaxxinity, Inc. portfolio CI brief
• Vaxxinity, Inc. pipeline updates RSS